The objectives of this proposal are to understand the physiological role of enterostatin in the regulation of dietary fat consumption and to define the peripheral and central pathways through which enterostatin modulates this effect. There are distinct and independent peripheral and central systems that are responsive to enterostatin. We hypothesize that enterostatin released in the stomach or duodenum acts as a paracrine factor to activate an afferent vagal pathway which innervates the central systems to modulate fat intake in the immediate meal. Further, we hypothesize that enterostatin acts within the brain as a tonic signal to regulate fat appetite through inhibition of a kappa-opioidergic system that is activated by dietary fat intake. We shall use a variety of experimental strategies and techniques to investigate these hypotheses. We shall use Northern blots, confocal immunohistochemistry and an ELISA assay to study the subcellular distribution of enterostatin in relation to vagal terminals and the regulation of enterostatin synthesis and secretion in response to dietary fat. The effects of intraluminal and near-arterial infusions of enterostatin on food intake will be studied and the role of the afferent vagus in this response investigated. The role of serotonergic signals in the central response to enterostatin will be further studied using local microdialysis. The effects of dietary fat and enterostatin on kappa opioidergic systems will be investigated through study of their effects on receptor ligand binding, receptor mRNA levels and the levels of dynorphin protein in specific brain regions. Finally, we shall use a ligand binding approach to isolate the enterostatin receptor from brain membranes or neuroblastoma cells and investigate the distribution and regulation of this receptor activity. As a result of these studies, we shall gain important insight into the peripheral and central systems that affect fat intake. This new information will provide the exciting possibility of the development of a pharmacological approach to reducing fat appetite as a means to improving the health of the American population.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
2R01DK045278-05
Application #
2016535
Study Section
Nutrition Study Section (NTN)
Project Start
1992-09-30
Project End
2000-11-30
Budget Start
1996-12-19
Budget End
1997-11-30
Support Year
5
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Lsu Pennington Biomedical Research Center
Department
Type
Organized Research Units
DUNS #
City
Baton Rouge
State
LA
Country
United States
Zip Code
70808
Ilnytska, Olha; Stütz, Adrian M; Park-York, MieJung et al. (2011) Molecular mechanisms for activation of the agouti-related protein and stimulation of appetite. Diabetes 60:97-106
Park, Miejung; Farrell, Jeffery; Lemmon, Karalee et al. (2009) Enterostatin alters protein trafficking to inhibit insulin secretion in Beta-TC6 cells. Peptides 30:1866-73
Park, Miejung; Oh, Hyoungil; York, David A (2009) Enterostatin affects cyclic AMP and ERK signaling pathways to regulate Agouti-related protein (AgRP) expression. Peptides 30:181-90
Park, M; Lyons 3rd, J; Oh, H et al. (2008) Enterostatin inhibition of angiogenesis: possible role of pAMPK and vascular endothelial growth factor A (VEGF-A). Int J Obes (Lond) 32:922-9
Lin, Ling; Park, Miejung; York, David A (2007) Enterostatin inhibition of dietary fat intake is modulated through the melanocortin system. Peptides 28:643-9
York, David A; Lin, Ling; Thomas, Sonjya R et al. (2006) Procolipase gene expression in the rat brain: source of endogenous enterostatin production in the brain. Brain Res 1087:52-9
Yang, Jichun; Wong, Ryan K; Park, MieJung et al. (2006) Leucine regulation of glucokinase and ATP synthase sensitizes glucose-induced insulin secretion in pancreatic beta-cells. Diabetes 55:193-201
Lin, Ling; Park, Miejung; Hulver, Matt et al. (2006) Different metabolic responses to central and peripheral injection of enterostatin. Am J Physiol Regul Integr Comp Physiol 290:R909-15
Lin, Ling; York, David A (2005) 5-HT1B receptors modulate the feeding inhibitory effects of enterostatin. Brain Res 1062:26-31
Lin, Ling; York, David A (2004) Amygdala enterostatin induces c-Fos expression in regions of hypothalamus that innervate the PVN. Brain Res 1020:147-53

Showing the most recent 10 out of 33 publications